{"url":"https://lda.senate.gov/api/v1/filings/5791c582-5ecd-4e12-b1e2-bfa0bd30c3e5/","filing_uuid":"5791c582-5ecd-4e12-b1e2-bfa0bd30c3e5","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2018,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/5791c582-5ecd-4e12-b1e2-bfa0bd30c3e5/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mark Roberts","dt_posted":"2018-04-13T18:29:56.317000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 New Jersey Ave NW","registrant_address_2":"Suite 350","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401103367,"url":"https://lda.senate.gov/api/v1/registrants/401103367/","house_registrant_id":null,"name":"LEAVITT PARTNERS, LLC","description":"Consulting.","address_1":"601 New Jersey Ave NW","address_2":"Suite 350","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK ROBERTS","contact_telephone":"+1 202-774-1404","dt_updated":"2026-07-07T10:50:17.833084-04:00"},"client":{"id":198726,"url":"https://lda.senate.gov/api/v1/clients/198726/","client_id":48,"name":"PAPCC COALITION","general_description":"pharmaceutical and patient safety issues","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-07-03"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61646,"prefix":null,"prefix_display":null,"first_name":"VINCE","nickname":null,"middle_name":null,"last_name":"VENTIMIGLIA","suffix":"jr","suffix_display":"JR"},"covered_position":"Assistant Secretary for Legislation - HHS; Legislative Assistant - Senate; Policy Director - Senate","new":false},{"lobbyist":{"id":61702,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LEE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant - Senate; Legislative Correspondent - Senate","new":false},{"lobbyist":{"id":67321,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"HORNE","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Energy and Commerce Committee - House; Senior Legislative Assistant - House; Legislative Assistant - House","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}